Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil

Clinical trial NCT05630313 · UNKNOWN

Trial details

NCT number: NCT05630313
Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Status: UNKNOWN
Study type: OBSERVATIONAL

Vaccine-induced Thrombotic Thrombocytopenia Syndrome Guillain-Barre Syndrome Acute Disseminated Encephalomyelitis Transverse Myelitis

Start date: 2022-10-04
Primary completion: 2023-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.